Migraine
📧 Sign up to get email alerts when something new happens for Migraine.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2025-06-19FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in changes to the product labeling.
-
FDA label_change · 2025-03-21FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for Aimovig (erenumab-aooe) submitted by Amgen. The approval updates the product labeling per the su…
-
FDA label_change · 2024-07-15FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Sun Pharmaceutical Industries, Inc. The action pertains to labeli…
-
FDA label_change · 2022-10-03FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab) submitted by Amgen, resulting in changes to the product labeling.
-
FDA label_change · 2022-03-31FDA Approved: NURTEC ODT — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for Nurtec ODT (rimegepant sulfate) from Pfizer, indicating a labeling change related to this migrai…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2021-06-30FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) submitted by Janssen Pharmaceuticals; the snippet does not specify the exac…
-
FDA label_change · 2021-05-11FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for Aimovig (erenumab-aooe) by Amgen.
-
FDA label_change · 2021-02-03FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
FDA approved a supplemental application for AIMOVIG (erenumab-aooe) filed by Amgen to update the product labeling.
-
FDA label_change · 2020-07-06FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for divalproex sodium from Zydus Pharmaceuticals USA Inc. to update the product labeling.
-
FDA label_change · 2020-04-30FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approves a supplemental application for AIMOVIG (erenumab-aooe) from Amgen, resulting in a labeling change.
-
FDA label_change · 2019-10-11FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hospira, Inc.)
FDA approves a supplemental application for butorphanol tartrate from Hospira, indicating changes to the product labeling for the generic.
-
FDA label_change · 2019-10-04FDA Approved: AIMOVIG — Supplemental Application (Amgen Inc)
The FDA approved a supplemental application for Aimovig (erenumab-aooe) from Amgen to update the product’s labeling.
-
FDA label_change · 2019-08-01FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Oceanside Pharmaceuticals)
FDA approved Oceanside Pharmaceuticals' supplemental application for Dihydroergotamine mesylate, updating the product labeling.
-
FDA label_change · 2018-12-27FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for TOPAMAX (topiramate) by Janssen Pharmaceuticals, Inc., resulting in labeling changes for the dru…
-
FDA label_change · 2017-10-05FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a labeling supplement for Depakote Sprinkles (divalproex sodium) submitted by AbbVie.
-
FDA label_change · 2017-10-05FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved AbbVie's supplemental application for Depakote (divalproex sodium), leading to changes to the product labeling.
-
FDA label_change · 2017-04-05FDA Approved: TROKENDI XR — Supplemental Application (Supernus Pharmaceuticals, Inc.)
FDA approved a supplemental application for TROKENDI XR (topiramate) from Supernus Pharmaceuticals, Inc., leading to labeling updates for th…
-
FDA label_change · 2016-05-19FDA Approved: DIVALPROEX SODIUM — Supplemental Application (NorthStar Rx LLC)
FDA supplemental application for divalproex sodium filed by NorthStar Rx LLC, likely involving labeling updates or other product changes. Th…
-
FDA label_change · 2015-09-14FDA Approved: NARATRIPTAN — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for Naratriptan from Hikma Pharmaceuticals USA Inc., typically resulting in changes to the drug'…
-
FDA label_change · 2015-05-11FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for DIVALPROEX SODIUM (Divalproex Sodium) from Zydus Pharmaceuticals USA Inc., resulting in labeling…
-
FDA label_change · 2014-11-08FDA Approved: DIVALPROEX SODIUM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for divalproex sodium submitted by Sun Pharmaceutical Industries to update the product labeling.
-
FDA label_change · 2014-06-20FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote Sprinkles (divalproex sodium) from AbbVie, updating regulatory information for the …
-
FDA label_change · 2014-05-29FDA Approved: MAXALT — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for MAXALT (rizatriptan benzoate) by Organon LLC.
-
FDA label_change · 2013-07-25FDA Approved: TOPAMAX — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for TOPAMAX (topiramate) filed by Janssen Pharmaceuticals, Inc. The approval updates the labelin…
-
FDA label_change · 2013-06-14FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie, resulting in labeling changes for the prod…